Epigenetic inactivation of IκB kinase-A in oral carcinomas and tumor progression

Clinical Cancer Research

Volumn 13, Issue 17, 2007, Pages 5041-5047

  Maeda, Genta ^a   Chiba, Tadashige ^a   Kawashiri, Shuichi ^b   Satoh, Tazuko ^a   Imai, Kazushi ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE LOCATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GROWTH; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; PROMOTER REGION; TUMOR CELL LINE;

CELL LINE, TUMOR; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE INSTABILITY; MOUTH NEOPLASMS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS);

EID: 34548844747     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-0463     Document Type: Article

References (50)

1. Lippman SM, Hong WK. Molecular markers of the risk of oral cavity. N Engl J Med 2001;344:1323-6.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics. CA Cancer J Clin 2005;55:10-30.
3. Ponder BAJ. Cancer genetics. Nature 2001;411:336-41.
4. Miyazawa J, Mitoro A, Kawashiri S, Chada KK, Imai K. Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity. Cancer Res 2004;64:2024-9.
5. Maeda G, Chiba T, Aoba T, Imai K. Epigenetic inactivation of E-cadherin by promoter hypermethylation in oral carcinoma cells. Odontology 2007;1:24-9.
6. Maeda G, Chiba T, Okazaki M, et al. Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int J Oncol 2005;27:1535-41.
7. Richter J, Wagner U, Schraml P, et al. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 1999;59:5687-91.
8. Alers JC, Rochat J, Krijtenburg PJ, et al. Identification of genetic markers for prostatic cancer progression. Lab Invest 2000;80:931-42.
9. Sansai I, Sellers WR. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 2004;22:2954-63.
10. Mavros A, Hahn M, Wieland I, et al. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity. J Oral Pathol Med 2002;31:270-6.
11. Chen Q, Samaranayake LP, Zhou H, Xiao L. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. Oral Oncol 2000;36:95-9.
12. van Waes C. Nuclear factor-κB in development, prevention, and therapy of cancer. Clin Cancer Res 2007;13:1076-82.
13. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-κB family proteins during oral carcinogenesis. Role of high risk human papillomavirus infection. Int J Cancer 2006;119:2840-50.
14. Yu M, Yeh J, van Waes C. Protein kinase case in kinase 2 mediates inhibitor-κB kinase and aberrant nuclear factor-κB activation by serum factor(s) in head and neck squamous carcinoma cells. Cancer Res 2006;66:6722-31.
15. Li Q, Antwerp D V, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science1999;284:321-5.
16. Makris C, Godfrey VL, Krahn-Senftleben G, et al. Female mice heterozygous for IKK γ/NEMO deficiencies developa dermatopathy similar to the human X-linked disorder incontinentia pigmenti. Mol Cell 2000;5:969-79.
17. Takeda K, Takeuchi O, Tsujimura T, et al. Limb and skin abnormalities inmice lacking IKKα. Science1999;284:313-6.
18. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation by mice lacking the IKKα subunit of IκB kinase. Science 1999;284:316-20.
19. Li Q, Lu Q, Hwang JY, et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 1999;13:1322-8.
20. Hermanek P, Sobin LH, editors. International Union against Cancer. TNM classification of malignant tumors. 4th ed. Berlin: Springer-Verlag; 1987.
21. Okuse T, Chiba T, Katsuumi I, Imai K. Differential expression and localization of WNTs in an animal model of skin wound healing. Wound Repair Regen 2005;13:491-7.
22. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
23. Strachan T, Read AP, editors. Human molecular genetics. 2nd ed. New York: John Wiley & Sons; 1999.
24. Shen CY, Yu JC, Lo YL, et al. Genome-wide search for loss of heterozygosity using laser capture micro-dissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. Cancer Res 2000;60:3884-92.
25. Choi SW, Lee KJ, Bae YA, et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002;8:2311-22.
26. Takai D, Jones PA. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci U S A 2002;99:3740-5.
27. Sighal RP. Modification of Escherichia coli glutamate transfer ribonucleic acid with bisulfite. J Biol Chem 1971;246:5848-51.
28. 2+. Differentiation 1993;54:201-17.
29. Kawabata H, Kawahara K, Kanekura T, et al. Possible role of transcriptional coactivator P/CAF and nuclear acetylation in calcium-induced keratinocyte differentiation. J Biol Chem 2002;277:8099-105.
30. An C, Choi IS, Yao JC, et al. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res 2005;11:656-63.
31. Dhillon VS, Aslam M, Husain A. The contribution of genetic and epigenetic changes in granulosa cell tumors of ovarian origin. Clin Cancer Res 2004;10:5537-45.
32. Brock MV, Gou M, Akiyama Y, et al. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 2003;9:2912-9.
33. Ahuja N, Mohan AL, Li Q, et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997;57:3370-4.
34. Koinuma K, Yamashita Y, Liu W, et al. Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 2006;25:139-46.
35. Gu L, Zhu N, Findley HW, Woods WG, Zhou M. Identification and characterization of the IKKα promoter. J Biol Chem 2004;279:52141-9.
36. Fuch E, Raghavan S. Getting under the skin of epidermal morphogenesis. Nat Rev Genet 2002;3:199-209.
37. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004;428:660-4.
38. Park KJ, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB. Formation of an IKKα-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 2005;18:71-82.
39. Kurita T, Cooke PS, Cunha GR. Epithelial-stromal tissue interaction in paramesonephric (Mullerian) epithelial differentiation. Dev Biol 2001;240:194-211.
40. Hu Y, Baud V, Oga T, Kim K, Yoshidda K, Karin M. IKKα controls formation of the epidermis independently of NF-κB. Nature 2001;410:710-4.
41. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, Gaynor RB. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 2003;423:655-9.
42. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, Baldwin AS. A nucleosomal function for IκB kinase-α in NF-κB - dependent gene expression. Nature 2003;423:659-63.
43. Harris H. Putting on the brakes. Nature 2004;427:201.
44. Liu B, Park E, Zhu F, et al. A critical role for IκB kinase α in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci U S A 2006;103:17202-7.
45. Nunn J, Nagini S, Risk JM, et al. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck. Oral Oncol 2003;39:115-29.
46. Nakagawa H, Nuova GJ, Zervos EE, et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001;61:6991-5.
47. Haydon AMM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002;3:83-8.
48. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28.
49. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000;405:482-5.
50. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, Tilghman SM. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 2000;405:486-9.